BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34625422)

  • 21. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer.
    Zhou Y; Jin X; Ma J; Ding D; Huang Z; Sheng H; Yan Y; Pan Y; Wei T; Wang L; Wu H; Huang H
    Cancer Res; 2021 Mar; 81(6):1486-1499. PubMed ID: 33419772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
    Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
    Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.
    Altintas DM; Shukla MS; Goutte-Gattat D; Angelov D; Rouault JP; Dimitrov S; Samarut J
    Mol Endocrinol; 2012 Sep; 26(9):1531-41. PubMed ID: 22771493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer.
    Shah N; Kesten N; Font-Tello A; Chang MEK; Vadhi R; Lim K; Flory MR; Cejas P; Mohammed H; Long HW; Brown M
    Cancer Res; 2020 Nov; 80(21):4612-4619. PubMed ID: 32934023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
    Kaur H; Samarska I; Lu J; Faisal F; Maughan BL; Murali S; Asrani K; Alshalalfa M; Antonarakis ES; Epstein JI; Joshu CE; Schaeffer EM; Mosquera JM; Lotan TL
    Prostate; 2020 Sep; 80(12):1012-1023. PubMed ID: 32649013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.
    Alpsoy A; Utturkar SM; Carter BC; Dhiman A; Torregrosa-Allen SE; Currie MP; Elzey BD; Dykhuizen EC
    Cancer Res; 2021 Feb; 81(4):820-833. PubMed ID: 33355184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
    Sharma S; Munger K
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
    Tyagi A; Agarwal C; Agarwal R
    Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
    Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
    Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.
    Logan IR; Gaughan L; McCracken SR; Sapountzi V; Leung HY; Robson CN
    Mol Cell Biol; 2006 Sep; 26(17):6502-10. PubMed ID: 16914734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1.
    Rogoff HA; Kowalik TF
    Cell Cycle; 2004 Jul; 3(7):845-6. PubMed ID: 15190206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
    Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
    Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
    J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.
    Lu H; Hallstrom TC
    J Biol Chem; 2013 Aug; 288(33):23833-43. PubMed ID: 23833190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of androgen receptor transcription through the E2F1/DNMT1 axis.
    Valdez CD; Davis JN; Odeh HM; Layfield TL; Cousineau CS; Berton TR; Johnson DG; Wojno KJ; Day ML
    PLoS One; 2011; 6(9):e25187. PubMed ID: 21966451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
    Iwahori S; Hakki M; Chou S; Kalejta RF
    J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.